GXO Logistics (GXO) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record revenue of $11.7 billion for 2024, up 20% year-over-year, with 3% organic growth and sequential acceleration each quarter.
Adjusted EBITDA reached $815 million for the year, exceeding guidance and growing 10% year-over-year.
Secured over $1 billion in new business wins for the second consecutive year, including a landmark $2.5 billion healthcare contract.
Completed the acquisition of Wincanton, expanding expertise in aerospace, industrials, and new geographies, notably Germany.
Customer satisfaction scores reached all-time highs, and the company received multiple industry awards.
Financial highlights
Q4 2024 revenue was $3.3 billion, up 25% year-over-year, with 4% organic growth; adjusted EBITDA was $251 million, up 30%.
Full-year adjusted diluted EPS was $2.80, up from $2.59 in 2023; net income was $138 million.
Operating income for 2024 was $218 million; Q4 net income was $100 million.
Free cash flow for Q4 was $127 million; full-year free cash flow conversion was 31%.
Net leverage reduced to 2.7x by year-end, with $2.2 billion in net debt.
Outlook and guidance
2025 organic revenue growth expected at 3%-6%, with adjusted EBITDA guidance of $840-$860 million.
Full-year adjusted diluted EPS guidance is $2.40-$2.60, reflecting higher tax rates.
Free cash flow conversion targeted at 25%-35% of adjusted EBITDA for 2025.
Q1 2025 adjusted EBITDA expected at $153–$157 million, with new business wins offsetting customer capacity realignment.
Integration benefits from Wincanton expected to ramp up after regulatory approval.
Latest events from GXO Logistics
- Record Q3 revenue and strong pipeline offset by lower net income from higher costs.GXO
Q3 20248 Jul 2026 - Board recommends approval of executive compensation, highlighting robust CEO transition and governance.GXO
Proxy filing13 May 2026 - Revenue up 11% to $3.3B, net income $5M, and 2026 guidance raised on strong pipeline and AI focus.GXO
Q1 20266 May 2026 - Record revenue, board refreshment, and strong ESG focus highlight this year's proxy.GXO
Proxy filing22 Apr 2026 - Record revenue and new business wins drive strong 2026 outlook and margin expansion.GXO
Q4 202511 Apr 2026 - Q2 revenue up 19% to $2.85B, but net income down 41% amid acquisition and litigation costs.GXO
Q2 20242 Feb 2026 - 2024 saw record results, board refreshment, and a focus on ESG and pay-for-performance.GXO
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 16%, guidance raised, Wincanton deal approved, CEO transition underway.GXO
Q2 202523 Nov 2025 - Q1 revenue up 21% to $3B, net loss $95M, guidance reaffirmed, and NHS contract boosts outlook.GXO
Q1 202519 Nov 2025